IL6 and diabetes mellitus: At the systemic level, IL-6 and CRP have been widely studied as markers of LGI in the context of diabetes because they are easily measurable inflammatory markers, widely correlated with the risk of developing the disease, and involved in the central biological processes of inflammation and insulin resistance [8].